BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ohmoto A, Fuji S. Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL. Blood Rev 2021;46:100738. [PMID: 32747325 DOI: 10.1016/j.blre.2020.100738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Zhang R, Liu L, Shen Y, Chen J, Qi T, Song W, Tang Y, Sun J, Lin Y, Xu S, Yang J, Lu H. Incidence and spectrum of infections among HIV/AIDS patients with lymphoma during chemotherapy. J Infect Chemother 2021;27:1459-64. [PMID: 34158238 DOI: 10.1016/j.jiac.2021.06.012] [Reference Citation Analysis]
2 Durmaz M, Visser O, Posthuma EFM, Brouwer RE, Issa DE, de Jong D, Lam KH, Blijlevens NMA, Zijlstra JM, Chamuleau MED, Lugtenburg PJ, Kersten MJ, Dinmohamed AG. Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018. Blood Cancer J 2022;12:38. [PMID: 35264598 DOI: 10.1038/s41408-022-00637-1] [Reference Citation Analysis]